These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 12229255)

  • 21. Beta-blockers in heart failure. The 'new wave' of clinical trials.
    Krum H
    Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Beta blockers in heart failure therapy with special reference to the COPERNICUS Study].
    Hartmann F; Katus HA
    Herz; 2002 Aug; 27 Suppl 1():30-4. PubMed ID: 12229256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.
    Franciosa JA; Massie BM; Lukas MA; Nelson JJ; Lottes S; Abraham WT; Fowler M; Gilbert EM; Greenberg B;
    Am Heart J; 2004 Oct; 148(4):718-26. PubMed ID: 15459606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. beta-blocker improvement in diastolic performance: the yin and yang of ventricular function changes.
    Eichhorn EJ; Grayburn PA
    Am Heart J; 2000 Apr; 139(4):584-6. PubMed ID: 10740138
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial].
    Costalunga A; Gavazzi A
    Ital Heart J Suppl; 2001 Nov; 2(11):1246-7. PubMed ID: 11775420
    [No Abstract]   [Full Text] [Related]  

  • 27. [Beta-blockers and heart failure--a critical view].
    Erdmann E
    Z Kardiol; 1996; 85 Suppl 7():35-8. PubMed ID: 9082682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-blockers in heart failure. 1. Clinical evidence.
    Nuttall SL; Langford NJ; Kendall MJ
    J Clin Pharm Ther; 2000 Dec; 25(6):395-8. PubMed ID: 11123492
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta blocker therapy after acute myocardial infarction in patients with heart failure and systolic dysfunction.
    Thattassery E; Gheorghiade M
    Heart Fail Rev; 2004 Apr; 9(2):107-13. PubMed ID: 15516858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.
    Frishman WH; Henderson LS; Lukas MA
    Vasc Health Risk Manag; 2008; 4(6):1387-400. PubMed ID: 19337551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-adrenergic blocking agents in the treatment of congestive heart failure: mechanisms and clinical results.
    Doughty RN; Sharpe N
    Annu Rev Med; 1997; 48():103-14. PubMed ID: 9046949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study].
    Ertl G; Nitschmann S
    Internist (Berl); 2004 Jul; 45(7):835-6. PubMed ID: 15054581
    [No Abstract]   [Full Text] [Related]  

  • 33. Carvedilol: a nonselective beta blocking agent with antioxidant properties.
    Book WM
    Congest Heart Fail; 2002; 8(3):173-7, 190. PubMed ID: 12045386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
    Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
    Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Slowing the progression of heart failure.
    Cohn JN
    Eur Heart J; 1996 Nov; 17(11):1609-11. PubMed ID: 8922902
    [No Abstract]   [Full Text] [Related]  

  • 36. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators.
    Vantrimpont P; Rouleau JL; Wun CC; Ciampi A; Klein M; Sussex B; Arnold JM; Moyé L; Pfeffer M
    J Am Coll Cardiol; 1997 Feb; 29(2):229-36. PubMed ID: 9014971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
    Fowler MB
    Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on pharmacological advances.
    Fonarow G
    J Invasive Cardiol; 2004 Sep; 16 Suppl E():2E-6E. PubMed ID: 23573649
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
    Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
    N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of beta-blocker therapy in treatment of coronary heart disease and sudden cardiac death with special reference to carvedilol].
    Zehender M; Just H
    Z Kardiol; 1996; 85 Suppl 7():23-9. PubMed ID: 9082680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.